Title: Full Text of SB0250
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of SB0250 ILGA.GOV SB0250 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB0250 Introduced 1/22/2025, by Sen. Laura Fine SYNOPSIS AS INTRODUCED: 410 ILCS 513/20    Amends the Genetic Information Privacy Act. Removes language exempting insurers that are issuing a long-term care policy from specified provisions. Provides that, with regard to any policy, contract, or plan offered, entered into, issued, amended, or renewed on or after January 1, 2026 by a health insurer, life insurer, or long-term care insurer authorized to transact insurance in this State, a health insurer, life insurer, or long-term care insurer may not: (1) cancel, limit, or deny coverage or establish differentials in premium rates based on a person's genetic information; or (2) require or solicit an individual's genetic information, use an individual's genetic test results, or consider an individual's decisions or actions relating to genetic information or a genetic test in any manner for any insurance purpose. Provides that the provisions may not be construed as preventing a life insurer or long-term care insurer from accessing an individual's medical record as part of an application exam. Provides that nothing in the provisions prohibits a life insurer or long-term care insurer from considering a medical diagnosis included in an individual's medical record, even if the diagnosis is based on the results of a genetic test. Effective July 1, 2025.LRB104 06028 BDA 16061 b  A BILL FOR SB0250LRB104 06028 BDA 16061 b1    AN ACT concerning health. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Genetic Information Privacy Act is amended 5by changing Section 20 as follows: 6    (410 ILCS 513/20)7    Sec. 20. Use of genetic testing information for insurance 8purposes. 9    (a) An insurer may not seek information derived from 10genetic testing for use in connection with a policy of 11accident and health insurance. Except as provided in 12subsection (c), an insurer that receives information derived 13from genetic testing, regardless of the source of that 14information, may not use the information for a nontherapeutic 15purpose as it relates to a policy of accident and health 16insurance.17    (b) An insurer shall not use or disclose protected health 18information that is genetic information for underwriting 19purposes. For purposes of this Section, "underwriting 20purposes" means, with respect to an insurer: 21        (1) rules for, or determination of, eligibility 22    (including enrollment and continued eligibility) for, or 23    determination of, benefits under the plan, coverage, or   SB0250- 2 -LRB104 06028 BDA 16061 b1    policy (including changes in deductibles or other 2    cost-sharing mechanisms in return for activities such as 3    completing a health risk assessment or participating in a 4    wellness program);5        (2) the computation of premium or contribution amounts 6    under the plan, coverage, or policy (including discounts, 7    rebates, payments in kind, or other premium differential 8    mechanisms in return for activities, such as completing a 9    health risk assessment or participating in a wellness 10    program);11        (3) the application of any pre-existing condition 12    exclusion under the plan, coverage, or policy; and13        (4) other activities related to the creation, renewal, 14    or replacement of a contract of health insurance or health 15    benefits. 16    "Underwriting purposes" does not include determinations of 17medical appropriateness where an individual seeks a benefit 18under the plan, coverage, or policy.19    This subsection (b) does not apply to insurers that are 20issuing a long-term care policy, excluding a nursing home 21fixed indemnity plan. 22    (c) An insurer may consider the results of genetic testing 23in connection with a policy of accident and health insurance 24if the individual voluntarily submits the results and the 25results are favorable to the individual.26    (d) An insurer that possesses information derived from   SB0250- 3 -LRB104 06028 BDA 16061 b1genetic testing may not release the information to a third 2party, except as specified in this Act.3    (e) A company providing direct-to-consumer commercial 4genetic testing is prohibited from sharing any genetic test 5information or other personally identifiable information about 6a consumer with any health or life insurance company without 7written consent from the consumer. 8    (f) A health insurer, life insurer, or long-term care 9insurer authorized to transact insurance in this State may 10not:11        (1) cancel, limit, or deny coverage or establish 12    differentials in premium rates based on a person's genetic 13    information; or14        (2) require or solicit an individual's genetic 15    information, use an individual's genetic test results, or 16    consider an individual's decisions or actions relating to 17    genetic information or a genetic test in any manner for 18    any insurance purpose.19    This subsection applies to any policy, contract, or plan 20that is offered, entered into, issued, amended, or renewed on 21or after January 1, 2026 by a health insurer, life insurer, or 22long-term care insurer authorized to transact insurance in 23this State. 24    (g) Nothing in this Section may be construed as preventing 25a life insurer or long-term care insurer from accessing an 26individual's medical record as part of an application exam.   SB0250- 4 -LRB104 06028 BDA 16061 b1Nothing in this Section prohibits a life insurer or long-term 2care insurer from considering a medical diagnosis included in 3an individual's medical record, even if the diagnosis is based 4on the results of a genetic test. 5(Source: P.A. 101-132, eff. 1-1-20.) 6    Section 99. Effective date. This Act takes effect July 1, 72025.


================================================================================

Raw Text:
Full Text of SB0250 ILGA.GOV SB0250 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB0250 Introduced 1/22/2025, by Sen. Laura Fine SYNOPSIS AS INTRODUCED: 410 ILCS 513/20    Amends the Genetic Information Privacy Act. Removes language exempting insurers that are issuing a long-term care policy from specified provisions. Provides that, with regard to any policy, contract, or plan offered, entered into, issued, amended, or renewed on or after January 1, 2026 by a health insurer, life insurer, or long-term care insurer authorized to transact insurance in this State, a health insurer, life insurer, or long-term care insurer may not: (1) cancel, limit, or deny coverage or establish differentials in premium rates based on a person's genetic information; or (2) require or solicit an individual's genetic information, use an individual's genetic test results, or consider an individual's decisions or actions relating to genetic information or a genetic test in any manner for any insurance purpose. Provides that the provisions may not be construed as preventing a life insurer or long-term care insurer from accessing an individual's medical record as part of an application exam. Provides that nothing in the provisions prohibits a life insurer or long-term care insurer from considering a medical diagnosis included in an individual's medical record, even if the diagnosis is based on the results of a genetic test. Effective July 1, 2025.LRB104 06028 BDA 16061 b  A BILL FOR SB0250LRB104 06028 BDA 16061 b1    AN ACT concerning health. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Genetic Information Privacy Act is amended 5by changing Section 20 as follows: 6    (410 ILCS 513/20)7    Sec. 20. Use of genetic testing information for insurance 8purposes. 9    (a) An insurer may not seek information derived from 10genetic testing for use in connection with a policy of 11accident and health insurance. Except as provided in 12subsection (c), an insurer that receives information derived 13from genetic testing, regardless of the source of that 14information, may not use the information for a nontherapeutic 15purpose as it relates to a policy of accident and health 16insurance.17    (b) An insurer shall not use or disclose protected health 18information that is genetic information for underwriting 19purposes. For purposes of this Section, "underwriting 20purposes" means, with respect to an insurer: 21        (1) rules for, or determination of, eligibility 22    (including enrollment and continued eligibility) for, or 23    determination of, benefits under the plan, coverage, or   SB0250- 2 -LRB104 06028 BDA 16061 b1    policy (including changes in deductibles or other 2    cost-sharing mechanisms in return for activities such as 3    completing a health risk assessment or participating in a 4    wellness program);5        (2) the computation of premium or contribution amounts 6    under the plan, coverage, or policy (including discounts, 7    rebates, payments in kind, or other premium differential 8    mechanisms in return for activities, such as completing a 9    health risk assessment or participating in a wellness 10    program);11        (3) the application of any pre-existing condition 12    exclusion under the plan, coverage, or policy; and13        (4) other activities related to the creation, renewal, 14    or replacement of a contract of health insurance or health 15    benefits. 16    "Underwriting purposes" does not include determinations of 17medical appropriateness where an individual seeks a benefit 18under the plan, coverage, or policy.19    This subsection (b) does not apply to insurers that are 20issuing a long-term care policy, excluding a nursing home 21fixed indemnity plan. 22    (c) An insurer may consider the results of genetic testing 23in connection with a policy of accident and health insurance 24if the individual voluntarily submits the results and the 25results are favorable to the individual.26    (d) An insurer that possesses information derived from   SB0250- 3 -LRB104 06028 BDA 16061 b1genetic testing may not release the information to a third 2party, except as specified in this Act.3    (e) A company providing direct-to-consumer commercial 4genetic testing is prohibited from sharing any genetic test 5information or other personally identifiable information about 6a consumer with any health or life insurance company without 7written consent from the consumer. 8    (f) A health insurer, life insurer, or long-term care 9insurer authorized to transact insurance in this State may 10not:11        (1) cancel, limit, or deny coverage or establish 12    differentials in premium rates based on a person's genetic 13    information; or14        (2) require or solicit an individual's genetic 15    information, use an individual's genetic test results, or 16    consider an individual's decisions or actions relating to 17    genetic information or a genetic test in any manner for 18    any insurance purpose.19    This subsection applies to any policy, contract, or plan 20that is offered, entered into, issued, amended, or renewed on 21or after January 1, 2026 by a health insurer, life insurer, or 22long-term care insurer authorized to transact insurance in 23this State. 24    (g) Nothing in this Section may be construed as preventing 25a life insurer or long-term care insurer from accessing an 26individual's medical record as part of an application exam.   SB0250- 4 -LRB104 06028 BDA 16061 b1Nothing in this Section prohibits a life insurer or long-term 2care insurer from considering a medical diagnosis included in 3an individual's medical record, even if the diagnosis is based 4on the results of a genetic test. 5(Source: P.A. 101-132, eff. 1-1-20.) 6    Section 99. Effective date. This Act takes effect July 1, 72025.